These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 773082)

  • 41. Letter: Clinical evaluation of clonidine in the treatment of migraine.
    White G
    Med J Aust; 1975 May; 1(21):663. PubMed ID: 1152724
    [No Abstract]   [Full Text] [Related]  

  • 42. Controlled clinical trial of ergotamine tartrate.
    Waters WE
    Br Med J; 1970 May; 2(5705):325-7. PubMed ID: 4913961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy and tolerance of an effervescent aspirin-metoclopramide combination in the treatment of a migraine attack. Randomized double-blind study using a placebo].
    Henry P; Hiesse-Provost O; Dillenschneider A; Ganry H; Insuasty J
    Presse Med; 1995 Feb; 24(5):254-8. PubMed ID: 7899379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clonidine against migraine.
    Wall MC; Wilkinson M
    Lancet; 1973 Sep; 2(7827):510. PubMed ID: 4125035
    [No Abstract]   [Full Text] [Related]  

  • 45. Clonidine in menopausal flushing: a double-blind trial.
    Bolli P; Simpson FO
    N Z Med J; 1975 Sep; 82(548):196-7. PubMed ID: 1105267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxprenolol in the treatment of migraine.
    Ekbom K; Zetterman M
    Acta Neurol Scand; 1977 Aug; 56(2):181-4. PubMed ID: 331835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
    Silberstein S; Saper J; Berenson F; Somogyi M; McCague K; D'Souza J
    Neurology; 2008 Feb; 70(7):548-55. PubMed ID: 18268247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Metoprolol, a new effective antimigraine agent].
    Raveau-Landon C; Bousser MG
    Presse Med; 1988 Oct; 17(35):1805-9. PubMed ID: 2978324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-term clinical trial of phopranolol in racemic form (Inderal), D-propranolol and placebo in migraine.
    Stensrud P; Sjaastad O
    Acta Neurol Scand; 1976 Mar; 53(3):229-32. PubMed ID: 773081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study.
    Pandya KJ; Raubertas RF; Flynn PJ; Hynes HE; Rosenbluth RJ; Kirshner JJ; Pierce HI; Dragalin V; Morrow GR
    Ann Intern Med; 2000 May; 132(10):788-93. PubMed ID: 10819701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Migraine prophylaxis with Lisuride hydrogen maleate--a double blind study of Lisuride versus placebo.
    Somerville BW; Herrmann WM
    Headache; 1978 May; 18(2):75-9. PubMed ID: 348647
    [No Abstract]   [Full Text] [Related]  

  • 54. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism.
    Fankhauser MP; Karumanchi VC; German ML; Yates A; Karumanchi SD
    J Clin Psychiatry; 1992 Mar; 53(3):77-82. PubMed ID: 1548248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of benefit of clonidine treatment for short stature in a double-blind, placebo-controlled trial.
    Pescovitz OH; Tan E
    Lancet; 1988 Oct; 2(8616):874-7. PubMed ID: 2902319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pirprofen in the treatment of migraine and episodic headache attacks: a placebo-controlled crossover clinical trial.
    Guidotti M; Zanasi S; Garagiola U
    J Int Med Res; 1989; 17(1):48-54. PubMed ID: 2651177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clonidine in acute migraine.
    Pozniak-Patewicz E
    Lancet; 1976 Oct; 2(7992):968. PubMed ID: 62200
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.
    Ebrahimi-Monfared M; Sharafkhah M; Abdolrazaghnejad A; Mohammadbeigi A; Faraji F
    Restor Neurol Neurosci; 2017; 35(4):385-393. PubMed ID: 28800342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.